Abstract
We present a 72-y-old woman with an osseous metastasis to the spine that had an atypical appearance on both nuclear medicine and radiologic modalities and was misdiagnosed as an abscess. We discuss the pitfalls of bone scintigraphy and the causes of photopenic metastatic lesions.
Despite its low specificity, bone scintigraphy is one of the most commonly ordered tests in the investigation of suspected skeletal metastases (1). Sclerotic metastases are typically radiopharmaceutical-avid on bone scintigraphy and on SPECT/CT. Metastases may show bone destruction or an extraosseous soft-tissue component (2). This is a case report of an atypical metastasis that was not avid on bone scans and had a large cystic component causing diagnostic uncertainty.
CASE REPORT
A 72-y-old woman presented with back pain and right-leg radiculopathy. Her past medical history included spindle-cell sarcoma of the left thigh treated with radiotherapy and surgery 1 y beforehand.
Contrast-enhanced CT demonstrated a ring-enhancing lesion involving the posterior elements of the right L4 vertebra, with a soft-tissue component extending into the neural foramen and spinal canal.
On MRI, the lesion was of a uniformly low T1 signal. The T2 signal was mixed, with fluid–fluid levels, consistent with intralesional hemorrhage. After gadolinium contrast administration, there was peripheral enhancement and central nonenhancement (Fig. 1).
The patient was afebrile, with a normal white cell count; however, C-reactive protein levels rose from 12 to 175 mg/L. The differential diagnosis was metastatic deposit versus infection.
Ultrasound-guided fine-needle aspiration was performed, and histologic examination revealed large numbers of neutrophils and other inflammatory cells, with no malignant cells, diagnostic of a paraspinal abscess.
Despite these results, there was ongoing concern and bone scintigraphy was performed. Whole-body imaging did not show any uptake of 99mTc-methylene diphosphonate (99mTc-MDP) tracer within the lesion (Fig. 2).
The SPECT/CT images showed bony destruction of the right L4 pedicle, a typical location for a metastasis (Fig. 3). Nuclear medicine findings played an important role by identifying the photopenic lesion associated with lysis and remaining suggestive despite the apparent false-negative whole-body study. This prompted CT-guided core biopsy. Histologic examination revealed malignant spindle cells with marked nuclear atypia and extensive necrosis, consistent with metastatic sarcoma. The patient proceeded with palliative radiotherapy.
DISCUSSION
Bone scans are frequently used to diagnose osseous metastases, with high sensitivity rates of 95% (3). However, lesions can be photopenic, and the interpreter must be aware of the causes for this. In our case, the highly aggressive, lytic nature of the lesion was the likely cause. For aggressive tumors such as this, 18F-FDG PET/CT can play a complementary role and is indicated in staging for various types of sarcomas. Other photopenic osteolytic tumors include hepatocellular, renal, thyroid carcinoma, and tumors that are confined to the bone marrow such as myeloma and lymphoma (4).
The case highlights the importance of SPECT/CT as an adjunct to whole-body imaging, as the CT component adds significant information toward the overall diagnosis. The case also emphasizes the importance of a thorough review of prior cross-sectional imaging.
A final teaching point this case highlights is the sampling error inherent in fine-needle aspiration. Core biopsy should always be preferentially obtained for conclusive histologic results.
CONCLUSION
Metastatic osseous disease is frequently investigated with bone scintigraphy. It is important for staff involved in nuclear medicine to be aware of potential pitfalls and causes of false-negative whole-body imaging. Correlation with SPECT/CT is crucial for detection of associated features of malignancy, particularly in unusual cases.
DISCLOSURE
No potential conflict of interest relevant to this article was reported.
Footnotes
Published online Dec. 6, 2019.
- Received for publication July 31, 2019.
- Accepted for publication October 16, 2019.